Search
for
Sort by
Research 31–60 of 333
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Atypical folliculitis caused by Malassezia spp. in immunosuppressed patients
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- The management and treatment of acne
- Pyodermatitis vegetans associated with multiple myeloma
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Use of Plasma-Rich in Growth Factors (PRGF) in the Treatment of Acne
- Topical retinoids: role and place in acne therapy
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- SnapshotDx Quiz: January 2021
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Treatment of acne with intermittent isotretinoin, cohort study
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Acne related to dietary supplements
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Eosinophilic Pustular Folliculitis Mimicking Varicella: A Diagnostic Challenge in an Adolescent Patient
- Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging
- 1030 EGFR protects the upper hair follicle from staphylococcus driven folliculitis
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Minoxidil
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?